A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Eligibility criteria
Qualifiers
Age ≥18
Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Disqualifiers
Metal implants that are not suitable for MRI
Inability or unwillingness of individual to give written informed consent.
Trial design
Treatments tested in this trial
- Cardiovascular Magnetic Resonance (CMR)
Treatment groups
25 Participants
are divided into 1 treatment groupLocations
1Mayo Clinic55905, RochesterMinnesota, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov